Breaking News: Dermata Therapeutics (NASDAQ:DRMA) Stock Surges with Heavy Pre-Market Trading
Dermata Therapeutics (NASDAQ:DRMA) stock is making big moves today, with over 13 million shares of DRMA stock traded pre-market. This is a significant increase from its average daily trading volume of 88,000 shares. It’s important to note that the float for Dermata Therapeutics is only 433,330 shares.
Despite the surge in trading, there is no news from Dermata Therapeutics today, including press releases or SEC filings. Additionally, there is no analyst coverage driving the stock’s rally.
DRMA is considered a penny stock due to its low trading volume, prior closing price of $1.30, and market capitalization of $901,127. This classification brings certain risks, including high volatility and potential for loss.
Yesterday, DRMA stock fell 22.6% during regular trading hours, with 1.4 million shares traded. This highlights the risky nature of investing in penny stocks.
As of Wednesday morning, DRMA stock is up 200%, making it an attractive but volatile investment option. Investors should proceed with caution and stay informed about the latest stock market news.
In summary, while Dermata Therapeutics is experiencing a surge in trading activity and stock price, investors should be aware of the risks associated with penny stocks. High volatility and potential for loss make DRMA a risky investment choice. Stay informed and cautious when considering investing in DRMA stock.